An interventional study of LOAM Fiber-based Sweetener and Sugar in Postprandial Glucose and GI Tolerance, sponsored by LOAM Science. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by LOAM Science · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study is using a double-blind, randomize crossover evaluating the impact of three different sweeteners on postprandial glycemic response in a mixed meal setting. In 50 individuals, postprandial glucose response will be evaluated as a primary objective. Secondary objectives include additional measures of glucose response as well general gastrointestinal response to the sweeteners, assessed through a series of questionnaires.
LOAM Science is the lead sponsor of 4 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Sugar, stevia, and a fiber-based alternative sweetener will be evaluated in a pre-defined order.
Dietary Supplement: LOAM Fiber-based Sweetener · Other: Sugar · Other: Stevia
Sugar, stevia, and a fiber-based alternative sweetener will be evaluated in a pre-defined order.
Dietary Supplement: LOAM Fiber-based Sweetener · Other: Sugar · Other: Stevia
Sugar, stevia, and a fiber-based alternative sweetener will be evaluated in a pre-defined order.
Dietary Supplement: LOAM Fiber-based Sweetener · Other: Sugar · Other: Stevia
Sugar, stevia, and a fiber-based alternative sweetener will be evaluated in a pre-defined order.
Dietary Supplement: LOAM Fiber-based Sweetener · Other: Sugar · Other: Stevia
Sugar, stevia, and a fiber-based alternative sweetener will be evaluated in a pre-defined order.
Dietary Supplement: LOAM Fiber-based Sweetener · Other: Sugar · Other: Stevia
Sugar, stevia, and a fiber-based alternative sweetener will be evaluated in a pre-defined order.
Dietary Supplement: LOAM Fiber-based Sweetener · Other: Sugar · Other: Stevia
A fiber-based sweetener produced by LOAM.
Table sugar
Stevia
Postprandial Area Under the Curve to 120 Minutes
Area under the curve above baseline from time zero (the start of the preload consumption) through 120 minutes. Baseline is defined as the mean glucose over the 15 minutes prior to the preload consumption. Area falling below baseline will be excluded.
Time frame: Data will be collected on each day of supplementation, days 3, 4, 6, 7, 9, and 10.
Postprandial Area Under the Curve to 180 Minutes
Area under the curve above baseline from time zero (the start of the preload consumption) through 180 minutes. Baseline is defined as the mean glucose over the 15 minutes prior to the preload consumption. Area falling below baseline will be excluded.
Time frame: Data will be collected on each day of supplementation, days 3, 4, 6, 7, 9, and 10.
Postprandial Area Under the Curve to 120 Minutes Relative to Start of the Meal
Area under the curve above baseline from time zero (the start of the meal consumption) through 120 minutes. Baseline is defined as the mean glucose over the 15 minutes prior to the preload consumption. Area falling below baseline will be excluded.
Time frame: Data will be collected on each day of supplementation, days 3, 4, 6, 7, 9, and 10.
Peak Glucose
Maximum observed glucose peak over the course of the 180 minute window.
Time frame: Data will be collected on each day of supplementation, days 3, 4, 6, 7, 9, and 10.
Incremental Peak Glucose
Maximum observed glucose peak relative to baseline over the course of the 180 minute window.
Time frame: Data will be collected on each day of supplementation, days 3, 4, 6, 7, 9, and 10.
Time to Peak
Elapsed time from preload consumption to the maximum observed value.
Time frame: Data will be collected on each day of supplementation, days 3, 4, 6, 7, 9, and 10.
Post-Meal Subjective State
Fullness, hunger, energy, and gastrointestinal comfort on a 0-10 numerical rating scale with 10 being an optimal situation and 0 representing the inverse for fullness, energy, and gastrointestinal comfort and 0 being an optimal situation and 10 representing the inverse for hunger. Questions are asked 60 and 180 minutes after the start of the mixed meal.
Time frame: Data will be collected on each day of supplementation, days 3, 4, 6, 7, 9, and 10.
Plan to share: No — IPD is proprietary information.
No publications or documents are linked to this record.
Started Nov 2026 (actual). Primary completion is estimated for Jan 2027, 2 months after the start.
Start moved once since we started tracking on Sep 25, 2026: Dec 2026 → Nov 2026, on Nov 12, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
LOAM Science